Improving predictive modeling in pediatric drug development: Pharmacokinetics, pharmacodynamics, and mechanistic modeling

William Slikker, John F. Young, Richard A. Corley, David C. Dorman, Rory B. Conolly, Thomas B. Knudsen, Brian L Erstad, Richard H. Luecke, Elaine M. Faustman, Charles Timchalk, Donald R. Mattison

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A workshop was conducted on November 18-19, 2004, to address the issue of improving predictive models for drug delivery to developing humans. Although considerable progress has been made for adult humans, large gaps remain for predicting pharmacokinetic/pharmacodynamic (PK/PD) outcome in children because most adult models have not been tested during development. The goals of the meeting included a description of when, during development, infants/children become adultlike in handling drugs. The issue of incorporating the most recent advances into the predictive models was also addressed: both the use of imaging approaches and genomic information were considered. Disease state, as exemplified by obesity, was addressed as a modifier of drug pharmacokinetics and pharmacodynamics during development. Issues addressed in this workshop should be considered in the development of new predictive and mechanistic models of drug kinetics and dynamics in the developing human.

Original languageEnglish (US)
Pages (from-to)505-518
Number of pages14
JournalAnnals of the New York Academy of Sciences
Volume1053
DOIs
StatePublished - 2005

Fingerprint

Pharmacodynamics
Pediatrics
Pharmacokinetics
Child Development
Pharmaceutical Preparations
Education
Obesity
Drug delivery
Imaging techniques
Kinetics
Drugs
Modeling

Keywords

  • Children
  • Modeling
  • PBPK
  • Pediatrics
  • Pharmacodynamics
  • Pharmacokinetics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Slikker, W., Young, J. F., Corley, R. A., Dorman, D. C., Conolly, R. B., Knudsen, T. B., ... Mattison, D. R. (2005). Improving predictive modeling in pediatric drug development: Pharmacokinetics, pharmacodynamics, and mechanistic modeling. Annals of the New York Academy of Sciences, 1053, 505-518. https://doi.org/10.1196/annals.1344.044

Improving predictive modeling in pediatric drug development : Pharmacokinetics, pharmacodynamics, and mechanistic modeling. / Slikker, William; Young, John F.; Corley, Richard A.; Dorman, David C.; Conolly, Rory B.; Knudsen, Thomas B.; Erstad, Brian L; Luecke, Richard H.; Faustman, Elaine M.; Timchalk, Charles; Mattison, Donald R.

In: Annals of the New York Academy of Sciences, Vol. 1053, 2005, p. 505-518.

Research output: Contribution to journalArticle

Slikker, W, Young, JF, Corley, RA, Dorman, DC, Conolly, RB, Knudsen, TB, Erstad, BL, Luecke, RH, Faustman, EM, Timchalk, C & Mattison, DR 2005, 'Improving predictive modeling in pediatric drug development: Pharmacokinetics, pharmacodynamics, and mechanistic modeling', Annals of the New York Academy of Sciences, vol. 1053, pp. 505-518. https://doi.org/10.1196/annals.1344.044
Slikker, William ; Young, John F. ; Corley, Richard A. ; Dorman, David C. ; Conolly, Rory B. ; Knudsen, Thomas B. ; Erstad, Brian L ; Luecke, Richard H. ; Faustman, Elaine M. ; Timchalk, Charles ; Mattison, Donald R. / Improving predictive modeling in pediatric drug development : Pharmacokinetics, pharmacodynamics, and mechanistic modeling. In: Annals of the New York Academy of Sciences. 2005 ; Vol. 1053. pp. 505-518.
@article{ce504e940ee24b0e835feda340583cda,
title = "Improving predictive modeling in pediatric drug development: Pharmacokinetics, pharmacodynamics, and mechanistic modeling",
abstract = "A workshop was conducted on November 18-19, 2004, to address the issue of improving predictive models for drug delivery to developing humans. Although considerable progress has been made for adult humans, large gaps remain for predicting pharmacokinetic/pharmacodynamic (PK/PD) outcome in children because most adult models have not been tested during development. The goals of the meeting included a description of when, during development, infants/children become adultlike in handling drugs. The issue of incorporating the most recent advances into the predictive models was also addressed: both the use of imaging approaches and genomic information were considered. Disease state, as exemplified by obesity, was addressed as a modifier of drug pharmacokinetics and pharmacodynamics during development. Issues addressed in this workshop should be considered in the development of new predictive and mechanistic models of drug kinetics and dynamics in the developing human.",
keywords = "Children, Modeling, PBPK, Pediatrics, Pharmacodynamics, Pharmacokinetics",
author = "William Slikker and Young, {John F.} and Corley, {Richard A.} and Dorman, {David C.} and Conolly, {Rory B.} and Knudsen, {Thomas B.} and Erstad, {Brian L} and Luecke, {Richard H.} and Faustman, {Elaine M.} and Charles Timchalk and Mattison, {Donald R.}",
year = "2005",
doi = "10.1196/annals.1344.044",
language = "English (US)",
volume = "1053",
pages = "505--518",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Improving predictive modeling in pediatric drug development

T2 - Pharmacokinetics, pharmacodynamics, and mechanistic modeling

AU - Slikker, William

AU - Young, John F.

AU - Corley, Richard A.

AU - Dorman, David C.

AU - Conolly, Rory B.

AU - Knudsen, Thomas B.

AU - Erstad, Brian L

AU - Luecke, Richard H.

AU - Faustman, Elaine M.

AU - Timchalk, Charles

AU - Mattison, Donald R.

PY - 2005

Y1 - 2005

N2 - A workshop was conducted on November 18-19, 2004, to address the issue of improving predictive models for drug delivery to developing humans. Although considerable progress has been made for adult humans, large gaps remain for predicting pharmacokinetic/pharmacodynamic (PK/PD) outcome in children because most adult models have not been tested during development. The goals of the meeting included a description of when, during development, infants/children become adultlike in handling drugs. The issue of incorporating the most recent advances into the predictive models was also addressed: both the use of imaging approaches and genomic information were considered. Disease state, as exemplified by obesity, was addressed as a modifier of drug pharmacokinetics and pharmacodynamics during development. Issues addressed in this workshop should be considered in the development of new predictive and mechanistic models of drug kinetics and dynamics in the developing human.

AB - A workshop was conducted on November 18-19, 2004, to address the issue of improving predictive models for drug delivery to developing humans. Although considerable progress has been made for adult humans, large gaps remain for predicting pharmacokinetic/pharmacodynamic (PK/PD) outcome in children because most adult models have not been tested during development. The goals of the meeting included a description of when, during development, infants/children become adultlike in handling drugs. The issue of incorporating the most recent advances into the predictive models was also addressed: both the use of imaging approaches and genomic information were considered. Disease state, as exemplified by obesity, was addressed as a modifier of drug pharmacokinetics and pharmacodynamics during development. Issues addressed in this workshop should be considered in the development of new predictive and mechanistic models of drug kinetics and dynamics in the developing human.

KW - Children

KW - Modeling

KW - PBPK

KW - Pediatrics

KW - Pharmacodynamics

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=29744453272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29744453272&partnerID=8YFLogxK

U2 - 10.1196/annals.1344.044

DO - 10.1196/annals.1344.044

M3 - Article

C2 - 16179559

AN - SCOPUS:29744453272

VL - 1053

SP - 505

EP - 518

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -